Noorik Biopharmaceuticals announces the signing of a development contract with the Federal Government of Switzerland to develop ambrisentan as a treatment for severe COVID-19
December 15, 2021
December 15, 2021
December 14, 2021
December 14, 2021
December 14, 2021
December 13, 2021
December 13, 2021
December 9, 2021
December 9, 2021
December 9, 2021
October 29, 2025
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible EazeBio today announced a ...
October 9, 2025
Alithea Genomics, a leader in next-generation transcriptomic solutions, today announced the commercial launch of MERCURIUS™ Spheroid DRUG-seq, a novel...
October 6, 2025
AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225